Newsroom

Group picture
Story
Results of the nationwide antibody study
From July 2020 to August 2021, a research team from the HZI, with external support, studied the antibody status of more than 26,000 people in seven county districts and thus collected important data on the pandemic event.
02.12.2021
HZI Campus
buch
Story
“There will be other, perhaps even more dangerous pandemics”
Though the Corona pandemic is not over yet, we should already start preparing for future pandemics. A look at what infection research can contribute.
02.12.2021
HZI Campus
HIOH
Immunfluoreszenz-Aufnahme der Lunge
News
COVID-19-related respiratory failure: Why patients require prolonged ventilation
30.11.2021
HIRI
Immunotherapy against hepatitis B
News
Who benefits from immunotherapy against hepatitis B?
Hepatitis B is a viral infection of the liver that can lead to cancer and organ failure. Antiviral therapies can suppress the infection, but a functional cure is rare. Novel immunotherapies may lead to an actual cure more often. However, it is still unclear which patients benefit most from these new therapies. Researchers at the Centre for Individualised Infection Medicine (CiiM), a joint institution of the Helmholtz Centre for Infection Research (HZI) and the Hannover Medical School (MHH), as well as the MHH and the German Center for Infection Research (DZIF), have now identified a biomarker that intends to enable predictions about the success of the therapy. The results were published in the scientific journal Gut.
25.11.2021
CiiM
Infection and immunity week
News
Joint symposium of HZI and McGill University on personalised infection medicine
The Helmholtz Centre for Infection Research (HZI) in Braunschweig and the McGill Interdisciplinary Initiative in Infection and Immunity (MI4) at McGill University in Montréal, Canada, are organising a joint symposium on personalised infection medicine on 29 November. Three researchers from each of the two institutions will give lectures on various topics of personalised infection medicine. The keynote lecture will be given by Prof Ugur Sahin, co-founder and CEO of BioNTech SE. The symposium kicks off McGill University's “Infection and Immunity Week”, which celebrates its 200th anniversary this year. Interested scientists can register to follow the event online.
23.11.2021
HZI Campus
CiiM
HIRI
Filterplättchen
News
20 research, medical and pharmaceutical organizations call on G7 to step up action against antibiotic resistance
Ahead of the “World Antimicrobial Awareness Week” (November 18-24) 20 national and international organizations from academia, healthcare and the pharmaceutical industry appealed today to G7 governments to step up efforts to tackle the problem of growing antibiotic resistance. Their "Joint Statement on Strengthening the Antibiotic R&D Pipeline by Rewarding Innovation" stresses that only an approach involving both the public and private sectors is likely to succeed. The Helmholtz Centre for Infection Research (HZI) is a member of the Helmholtz Association of German Research Centres and the German Center for Infection Research (DZIF), which both signed the statement.
17.11.2021
HZI Campus

HZI in the media

Parkinson's drug tolcapone found to block key protein in hospital superbug

s drug tolcapone. HIPS is a site of the Helmholtz Center for Infection Research (HZI) in collaboration with Saarland University.

 

The

26.11.2025
|
Medical Xpress
„RNA Healer“ erhält rund eine Million Euro für Entwicklung von Leberfibrose-Therapie

... erhielt das Projekt „Citrapeutics“ vom Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig eine Förderung in Höhe ...

25.11.2025
|
Bionity.COM
Pattern of chronic rejection for liver transplants decoded

led by Hannover Medical School (MHH) and the Helmholtz Center for Infection Research (HZI) has now discovered clear molecular signatures for

24.11.2025
|
Medical Xpress
Lebertransplantation: Muster der chronischen Abstoßung entschlüsselt

Medizinischen Hochschule Hannover (MHH) und dem Helmholtz-Zentrum für Infektionsforschung (HZI), hat nun eindeutige molekulare Signaturen ...

24.11.2025
|
DeutschesGesundheitsPortal
HZI bringt Wissenschaft zum Anfassen in die Innenstadt

Braunschweig. Das Helmholtz-Zentrum für Infektionsforschung (HZI) bringt anlässlich seines 60. Jubiläums seine Forschung vom 3. ...

22.11.2025
|
Regional Heute
Millionenförderung für Forschung an intelligenten Implantaten

Universität Hannover (LUH), dem Helmholtz Zentrum für Infektionsforschung (HZI) in Braunschweig, der Technischen Universität Braunschweig ...

21.11.2025
|
Medizinische Hochschule Hannover
HZI im Wissenschaftsschaufenster – Forschung zum Anfassen in der Braunschweiger Innenstadt

... 38100 Braunschweig Das Helmholtz-Zentrum für Infektionsforschung: Wissenschaftler:innen am Helmholtz-Zentrum für Infektionsforschung ( ...

20.11.2025
|
Bochumer-Zeitung
Wie Grippe den Körper nachhaltig beeinflusst

Dr. Dunja Bruder ist Forschungsgruppenleiterin am Helmholtz-Zentrum für Infektionsforschung in Braunschweig und zugleich Professorin für

20.11.2025
|
Bilanz
Warum ältere Menschen schlechter auf Impfungen reagieren

... Wissenschaftler und Wissenschaftlerinnen des Helmholtz-Zentrums für Infektionsforschung (HZI) und der Medizinischen Hochschule ...

19.11.2025
|
Rheinische Post
Die Suche nach neuen Waffen gegen bakterielle Infektionen

... Forschungsschwerpunkt „Neue Antiinfektiva“ des Helmholtz-Zentrums für Infektionsforschung (HZI) entwickeln fast 20 Forschungsgruppen neue ...

18.11.2025
|
Regional Heute
Polioviren vom Wildtyp 1 in Hamburger Abwasserprobe nachgewiesen

... , Stellvertretende Teamleiterin der Klinischen Epidemiologie am Helmholtz-Zentrum für Infektionsforschung (HZI), Braunschweig.

17.11.2025
|
Biermann Medizin
Darmmikrobiom: Billionen Bakterien steuern unser Immunsystem

... und individueller Darmflora ab.

 

Forscher am Helmholtz-Zentrum für Infektionsforschung arbeiten bereits an der nächsten Generation ...

14.11.2025
|
Ad Hoc News

Register now for the HZI-Newsletter